synced 2 MIN AGO
01 Record

CVE-2025-2229

Philips Intellispace Cardiovascular (ISCV) Use of Weak Credentials

HighPUBLISHEDCNA: icscert
CNA base score8.5 CVSS v4.0CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N

02 Description

Philips Intellispace Cardiovascular (ISCV) Use of Weak Credentials

03 Exploitation and scoring

Exploitation
Assessed, none found. CISA's assessment recorded neither public exploit code nor evidence of exploitation when it was made.
SSVC decision
  • ExploitationnoneCISA recorded no public exploit code and no evidence of exploitation.
  • AutomatablenoAt least one step from reconnaissance to exploitation cannot be reliably automated.
  • Technical ImpacttotalSuccessful exploitation gives total control of the vulnerable component.
CISA publishes the decision points, not a final SSVC decision. The decision also depends on mission and well-being impact, which is a property of your deployment rather than of the vulnerability.
EPSS probability
0.12% probability of exploitation activity in the next 30 days.
EPSS percentile
Equal to or higher than the score of 2.0% of scored records. A rank, not a probability.
NVD base score
8.5 (CVSS v4.0), scored by the NVD independently of the CNA.
NVD CVSS vector
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
NVD analysis status
Deferred. NVD last modified this record on 2026-06-17.
Red Hat severity
No Red Hat rating. Red Hat rates the CVEs that affect its products.

Exploit-prediction scores from FIRST. Independent scoring and analysis status from the NVD. Vendor severity from Red Hat. Exploitation assessment and catalog membership from CISA.

04 Metadata

Published
2025-03-13 18:17Z1 YR AGO
Last updated
2025-03-17 20:04Z1 YR AGO
Reserved
2025-03-11
Assigning CNA
icscert
Record state
PUBLISHED
Severity
High (CVSS 8.5)
CNA CVSS vector
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N
Weaknesses
Data version
5.1
Document digest
0b01f31d7f041ff6ef633c77f00ab5e6318ef413b06d45e1faa31b937dc7caa1

05 Affected products

VendorProductVersionsPlatforms

06 References

07 Remediation

Philips recommends the following mitigations: * Resolved in ISCV 4.2 build 20589, which was released in May 2019. * Philips recommends users upgrade ISCV installed base to the latest ISCV version (at the time of this publication is 830089 – IntelliSpace Cardiovacular 8.0.0.0) * Please contact a local Philips sales (service) representative to learn how to engage this upgrade process. * For managed services users, new releases will be made available upon resource availability. Releases are subject to country-specific regulations. Refer to the Philips advisory https://www.philips.com/a-w/security/security-advisories.html for more details.